Performance of the CARDIOGARD Cannula

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT02764645

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02764645
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02764645. Randomized; single masking; primary purpose prevention. Start 2016-05 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Performance of the CARDIOGARD Cannula
Acronym
GECG
Condition
Heart Valve Diseases
Intervention (Device)
CardioGard Cannula
Intervention (Device)
22Fr curved Cannula
Lead sponsor
Rambam Health Care Campus (class: other)
Collaborator
CardioGard Medical Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02764645
Content hash
e589de334cea352d153d1defe281b7466ab99f0c77f11d4fda81499dc1737aea